158 related articles for article (PubMed ID: 7546047)
21. Chagas Disease: A Solvable Problem, Ignored.
Tarleton RL
Trends Mol Med; 2016 Oct; 22(10):835-838. PubMed ID: 27523778
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo antiproliferative and trypanocidal activities of ruthenium NO donors.
Silva JJ; Osakabe AL; Pavanelli WR; Silva JS; Franco DW
Br J Pharmacol; 2007 Sep; 152(1):112-21. PubMed ID: 17603548
[TBL] [Abstract][Full Text] [Related]
23. Activity of lytic peptides against intracellular Trypanosoma cruzi amastigotes in vitro and parasitemias in mice.
Barr SC; Rose D; Jaynes JM
J Parasitol; 1995 Dec; 81(6):974-8. PubMed ID: 8544074
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo studies of the biological activity of novel arylimidamides against Trypanosoma cruzi.
De Araújo JS; Da Silva CF; Batista DG; Da Silva PB; Meuser MB; Aiub CA; da Silva MF; Araújo-Lima CF; Banerjee M; Farahat AA; Stephens CE; Kumar A; Boykin DW; Soeiro MN
Antimicrob Agents Chemother; 2014 Jul; 58(7):4191-5. PubMed ID: 24590476
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of proline analogs as trypanocidal agents through the inhibition of a Trypanosoma cruzi proline transporter.
Sayé M; Fargnoli L; Reigada C; Labadie GR; Pereira CA
Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2913-2921. PubMed ID: 28844978
[TBL] [Abstract][Full Text] [Related]
26. Anti-Trypanosoma cruzi action of a new benzofuran derivative based on amiodarone structure.
Pinto-Martinez A; Hernández-Rodríguez V; Rodríguez-Durán J; Hejchman E; Benaim G
Exp Parasitol; 2018 Jun; 189():8-15. PubMed ID: 29684665
[TBL] [Abstract][Full Text] [Related]
27. Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity.
Zingales B; Miles MA; Moraes CB; Luquetti A; Guhl F; Schijman AG; Ribeiro I; ;
Mem Inst Oswaldo Cruz; 2014 Sep; 109(6):828-33. PubMed ID: 25317712
[TBL] [Abstract][Full Text] [Related]
28. Can a killer be arrested?
Kierszenbaum F
Nat Med; 1996 Oct; 2(10):1071-2. PubMed ID: 8837597
[No Abstract] [Full Text] [Related]
29. Chagas Disease and Coumarins: A Review of Natural and Synthetic Coumarins As Anti-Trypanosoma Cruzi Agents.
Gonçalves GA; Cerecetto H; Poser GLV; Canto RFS; Eifler-Lima VL
Mini Rev Med Chem; 2021; 21(13):1701-1717. PubMed ID: 33372872
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo trypanocidal activity of the ethyl esters of N-allyl and N-propyl oxamates using different Trypanosoma cruzi strains.
Aguirre-Alvarado C; Zaragoza-Martínez F; Rodríguez-Páez L; Nogueda B; Baeza I; Wong C
J Enzyme Inhib Med Chem; 2007 Apr; 22(2):227-33. PubMed ID: 17518350
[TBL] [Abstract][Full Text] [Related]
31. Isoxazolylnaphthoquinone effects on the growth of Trypanosoma cruzi.
Amuchástegui PI; Moretti ER; Basso B; Sperandeo N; de Bertorello MM
Rev Argent Microbiol; 1990; 22(4):199-207. PubMed ID: 2129475
[TBL] [Abstract][Full Text] [Related]
32. Specific chemotherapy of Chagas disease: controversies and advances.
Urbina JA; Docampo R
Trends Parasitol; 2003 Nov; 19(11):495-501. PubMed ID: 14580960
[No Abstract] [Full Text] [Related]
33. In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole.
Murta SM; Romanha AJ
Parasitology; 1998 Feb; 116 ( Pt 2)():165-71. PubMed ID: 9509026
[TBL] [Abstract][Full Text] [Related]
34. Trypanocidal activity of 4 isopropyl salicylaldehyde and 4-isopropyl salicylic acid on Trypanosoma cruzi.
Nogueda-Torres B; Rodríguez-Paez L; Ramírez IB; Ramírez CW
Rev Latinoam Microbiol; 2001; 43(1):1-6. PubMed ID: 17061565
[TBL] [Abstract][Full Text] [Related]
35. 5-Nitro-2-furyl derivative actives against Trypanosoma cruzi: preliminary in vivo studies.
Cabrera E; Murguiondo MG; Arias MG; Arredondo C; Pintos C; Aguirre G; Fernández M; Basmadjián Y; Rosa R; Pacheco JP; Raymondo S; Di Maio R; González M; Cerecetto H
Eur J Med Chem; 2009 Oct; 44(10):3909-14. PubMed ID: 19446929
[TBL] [Abstract][Full Text] [Related]
36. Trypanocidal activity of (-)-cubebin derivatives against free amastigote forms of Trypanosoma cruzi.
de Souza VA; da Silva R; Pereira AC; Royo Vde A; Saraiva J; Montanheiro M; de Souza GH; da Silva Filho AA; Grando MD; Donate PM; Bastos JK; Albuquerque S; e Silva ML
Bioorg Med Chem Lett; 2005 Jan; 15(2):303-7. PubMed ID: 15603944
[TBL] [Abstract][Full Text] [Related]
37. Novel Diarylthioether Compounds as Agents for the Treatment of Chagas Disease.
Beveridge J; Tran E; Deora GS; Huang F; Wang Y; Stockton K; Cotillo I; Martinez Martinez MS; Gonzalez S; Castañeda P; Sherman J; Rodriguez A; Kessler A; Baell JB
J Med Chem; 2023 Jan; 66(2):1522-1542. PubMed ID: 36626662
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo trypanocidal activities of 8-methoxy-3-(4-nitrobenzoyl)-6-propyl-2H-cromen-2-one, a new synthetic coumarin of low cytotoxicity against mammalian cells.
Brancaglion GA; Toyota AE; Cardoso Machado JV; Fernandes Júnior AÁ; Silveira AT; Vilas Boas DF; Dos Santos EG; Caldas IS; Carvalho DT
Chem Biol Drug Des; 2018 Nov; 92(5):1888-1898. PubMed ID: 29992719
[TBL] [Abstract][Full Text] [Related]
39. Effects of artesunate against Trypanosma cruzi.
Olivera GC; Postan M; González MN
Exp Parasitol; 2015 Sep; 156():26-31. PubMed ID: 26024969
[TBL] [Abstract][Full Text] [Related]
40. Effects of immunosuppression and benzonidazole on Trypanosoma cruzi parasitism during experimental acute Chagas' disease.
Okumura M; Mester M; Iriya K; Amato Neto V; Gama-Rodrigues J
Transplant Proc; 1994 Jun; 26(3):1587-9. PubMed ID: 8030049
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
